Terms: = Ovarian cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566
108 results:
1. Sensitization of cancer cells to paclitaxel-induced apoptosis by canagliflozin.
Huang H; Kung FL; Huang YW; Hsu CC; Guh JH; Hsu LC
Biochem Pharmacol; 2024 May; 223():116140. PubMed ID: 38513740
[TBL] [Abstract] [Full Text] [Related]
2. Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer.
Boidot R; Blum MGB; Wissler MP; Gottin C; Ruzicka J; Chevrier S; Delhomme TM; Audoux J; Jeanniard A; Just PA; Harter P; Pignata S; González-Martin A; Marth C; Mäenpää J; Colombo N; Vergote I; Fujiwara K; Duforet-Frebourg N; Bertrand D; Philippe N; Ray-Coquard I; Pujade-Lauraine E;
Eur J Cancer; 2024 May; 202():113978. PubMed ID: 38471290
[TBL] [Abstract] [Full Text] [Related]
3. Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG study.
Chan JK; Tian C; Kesterson JP; Lin KY; Darcy K; Richardson MT; Kapp DS; Monk BJ; McNally L; Landrum L; Copeland L; Walker JL; Wenham RM; Phippen N; Spirtos NM; Tewari K; Shahin M; Berry L; Bell JG
Gynecol Oncol; 2024 Feb; 181():54-59. PubMed ID: 38134754
[TBL] [Abstract] [Full Text] [Related]
4. The Prognostic Significance of Adjuvant Chemotherapy in Adult ovarian Granulosa Cell Tumors: A Systematic Review and Meta-analysis.
Zhuang Y; Yang H
Cancer Control; 2023; 30():10732748231215165. PubMed ID: 37957122
[TBL] [Abstract] [Full Text] [Related]
5. Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
Morra A; Schreurs MAC; Andrulis IL; Anton-Culver H; Augustinsson A; Beckmann MW; Behrens S; Bojesen SE; Bolla MK; Brauch H; Broeks A; Buys SS; Camp NJ; Castelao JE; Cessna MH; Chang-Claude J; Chung WK; ; Colonna SV; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Dennis J; Devilee P; Dörk T; Dunning AM; Dwek M; Easton DF; Eccles DM; Eriksson M; Evans DG; Fasching PA; Fehm TN; Figueroa JD; Flyger H; Gabrielson M; Gago-Dominguez M; García-Closas M; García-Sáenz JA; Genkinger J; Grassmann F; Gündert M; Hahnen E; Haiman CA; Hamann U; Harrington PA; Hartikainen JM; Hoppe R; Hopper JL; Houlston RS; Howell A; ; ; Jakubowska A; Janni W; Jernström H; John EM; Johnson N; Jones ME; Kristensen VN; Kurian AW; Lambrechts D; Le Marchand L; Lindblom A; Lubiński J; Lux MP; Mannermaa A; Mavroudis D; Mulligan AM; Muranen TA; Nevanlinna H; Nevelsteen I; Neven P; Newman WG; Obi N; Offit K; Olshan AF; Park-Simon TW; Patel AV; Peterlongo P; Phillips KA; Plaseska-Karanfilska D; Polley EC; Presneau N; Pylkäs K; Rack B; Radice P; Rashid MU; Rhenius V; Robson M; Romero A; Saloustros E; Sawyer EJ; Schmutzler RK; Schuetze S; Scott C; Shah M; Smichkoska S; Southey MC; Tapper WJ; Teras LR; Tollenaar RAEM; Tomczyk K; Tomlinson I; Troester MA; Vachon CM; van Veen EM; Wang Q; Wendt C; Wildiers H; Winqvist R; Ziogas A; Hall P; Pharoah PDP; Adank MA; Hollestelle A; Schmidt MK; Hooning MJ
Cancer Med; 2023 Aug; 12(15):16142-16162. PubMed ID: 37401034
[TBL] [Abstract] [Full Text] [Related]
6. Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer.
Tang Q; Atiq W; Mahnoor S; Abdel-Maksoud MA; Aufy M; Yaz H; Zhu J
Oncol Res; 2023; 31(2):141-156. PubMed ID: 37304238
[TBL] [Abstract] [Full Text] [Related]
7. The association of macronutrient quality and its interactions with energy intake with survival among patients with ovarian cancer: results from a prospective cohort study.
Zheng G; Gong TT; Ma QP; Wei YF; Du ZD; Zhao JQ; Zou BJ; Yan S; Liu FH; Sun ML; Xiao Q; Gao S; Wu QJ; Zhao YH
Am J Clin Nutr; 2023 Jun; 117(6):1362-1371. PubMed ID: 37001589
[TBL] [Abstract] [Full Text] [Related]
8. The genetic basis of endometriosis and comorbidity with other pain and inflammatory conditions.
Rahmioglu N; Mortlock S; Ghiasi M; Møller PL; Stefansdottir L; Galarneau G; Turman C; Danning R; Law MH; Sapkota Y; Christofidou P; Skarp S; Giri A; Banasik K; Krassowski M; Lepamets M; Marciniak B; Nõukas M; Perro D; Sliz E; Sobalska-Kwapis M; Thorleifsson G; Topbas-Selcuki NF; Vitonis A; Westergaard D; Arnadottir R; Burgdorf KS; Campbell A; Cheuk CSK; Clementi C; Cook J; De Vivo I; DiVasta A; Dorien O; Donoghue JF; Edwards T; Fontanillas P; Fung JN; Geirsson RT; Girling JE; Harkki P; Harris HR; Healey M; Heikinheimo O; Holdsworth-Carson S; Hostettler IC; Houlden H; Houshdaran S; Irwin JC; Jarvelin MR; Kamatani Y; Kennedy SH; Kepka E; Kettunen J; Kubo M; Kulig B; Kurra V; Laivuori H; Laufer MR; Lindgren CM; MacGregor S; Mangino M; Martin NG; Matalliotaki C; Matalliotakis M; Murray AD; Ndungu A; Nezhat C; Olsen CM; Opoku-Anane J; Padmanabhan S; Paranjpe M; Peters M; Polak G; Porteous DJ; Rabban J; Rexrode KM; Romanowicz H; Saare M; Saavalainen L; Schork AJ; Sen S; Shafrir AL; Siewierska-Górska A; Słomka M; Smith BH; Smolarz B; Szaflik T; Szyłło K; Takahashi A; Terry KL; Tomassetti C; Treloar SA; Vanhie A; Vincent K; Vo KC; Werring DJ; Zeggini E; Zervou MI; ; ; ; ; ; Adachi S; Buring JE; Ridker PM; D'Hooghe T; Goulielmos GN; Hapangama DK; Hayward C; Horne AW; Low SK; Martikainen H; Chasman DI; Rogers PAW; Saunders PT; Sirota M; Spector T; Strapagiel D; Tung JY; Whiteman DC; Giudice LC; Velez-Edwards DR; Uimari O; Kraft P; Salumets A; Nyholt DR; Mägi R; Stefansson K; Becker CM; Yurttas-Beim P; Steinthorsdottir V; Nyegaard M; Missmer SA; Montgomery GW; Morris AP; Zondervan KT
Nat Genet; 2023 Mar; 55(3):423-436. PubMed ID: 36914876
[TBL] [Abstract] [Full Text] [Related]
9. Association of Frequent Aspirin Use With ovarian cancer Risk According to Genetic Susceptibility.
Hurwitz LM; Webb PM; Jordan SJ; Doherty JA; Harris HR; Goodman MT; Shvetsov YB; Modugno F; Moysich KB; Schildkraut JM; Berchuck A; Anton-Culver H; Ziogas A; Menon U; Ramus SJ; Wu AH; Pearce CL; Wentzensen N; Tworoger SS; Pharoah PDP; Trabert B
JAMA Netw Open; 2023 Feb; 6(2):e230666. PubMed ID: 36826816
[TBL] [Abstract] [Full Text] [Related]
10. Homologous recombination inquiry through ovarian malignancy investigations: JGOG3025 Study.
Yoshihara K; Baba T; Tokunaga H; Nishino K; Sekine M; Takamatsu S; Matsumura N; Yoshida H; Kajiyama H; Shimada M; Kagimura T; Oda K; Sasajima Y; Yaegashi N; Okamoto A; Sugiyama T; Enomoto T
Cancer Sci; 2023 Jun; 114(6):2515-2523. PubMed ID: 36747324
[TBL] [Abstract] [Full Text] [Related]
11. Identification of Biomarkers for ovarian cancer Diagnosis and Prognosis by Bioinformatics Analysis and q-PCR Validation.
Zheng Q; Ye H; Zhong H; Wang M
Ann Clin Lab Sci; 2022 Nov; 52(6):967-975. PubMed ID: 36564071
[TBL] [Abstract] [Full Text] [Related]
12. Association of hospital-level factors with utilization of sentinel lymph node biopsy in patients with early-stage vulvar cancer.
Bercow AS; Rauh-Hain JA; Melamed A; Mazina V; Growdon WB; Del Carmen MG; Goodman A; Bouberhan S; Randall T; Sisodia R; Bregar A; Eisenhauer EL; Minami C; Molina G
Gynecol Oncol; 2023 Feb; 169():47-54. PubMed ID: 36508758
[TBL] [Abstract] [Full Text] [Related]
13. A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib.
Guo M; Shu Y; Chen G; Li J; Li F
Sci Rep; 2022 Nov; 12(1):20601. PubMed ID: 36446798
[TBL] [Abstract] [Full Text] [Related]
14. ASPM, CDC20, DLGAP5, bub1b, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma.
Zhang Q; Wang Y; Xue F
Genet Res (Camb); 2022; 2022():3217248. PubMed ID: 36186000
[TBL] [Abstract] [Full Text] [Related]
15. Germline Missense Variants in CDC20 Result in Aberrant Mitotic Progression and Familial cancer.
Chen OJ; Castellsagué E; Moustafa-Kamal M; Nadaf J; Rivera B; Fahiminiya S; Wang Y; Gamache I; Pacifico C; Jiang L; Carrot-Zhang J; Witkowski L; Berghuis AM; Schönberger S; Schneider D; Hillmer M; Bens S; Siebert R; Stewart CJR; Zhang Z; Chao WCH; Greenwood CMT; Barford D; Tischkowitz M; Majewski J; Foulkes WD; Teodoro JG
Cancer Res; 2022 Oct; 82(19):3499-3515. PubMed ID: 35913887
[TBL] [Abstract] [Full Text] [Related]
16. IFNγ-induced PD-L1 expression in ovarian cancer cells is regulated by JAK1, STAT1 and IRF1 signaling.
Padmanabhan S; Gaire B; Zou Y; Uddin MM; Vancurova I
Cell Signal; 2022 Sep; 97():110400. PubMed ID: 35820543
[TBL] [Abstract] [Full Text] [Related]
17. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
Verdiesen RMG; van der Schouw YT; van Gils CH; Verschuren WMM; Broekmans FJM; Borges MC; Gonçalves Soares AL; Lawlor DA; Eliassen AH; Kraft P; Sandler DP; Harlow SD; Smith JA; Santoro N; Schoemaker MJ; Swerdlow AJ; Murray A; Ruth KS; Onland-Moret NC
Hum Reprod; 2022 May; 37(5):1069-1082. PubMed ID: 35274129
[TBL] [Abstract] [Full Text] [Related]
18. Does breast-conserving surgery with radiotherapy in BRCA-mutation carriers significantly increase ipsilateral breast tumor recurrence? A systematic review and meta-analysis.
Nara M; Ishihara S; Kitano A; Tamura N; Aruga T; Kobayashi D; Nakamura S; Yamauchi H
Breast Cancer; 2022 May; 29(3):394-401. PubMed ID: 35212965
[TBL] [Abstract] [Full Text] [Related]
19. Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis.
Qin W; Yuan Q; Liu Y; Zeng Y; Ke D; Dai X; Shuai Y; Hu J; Shi H
Taiwan J Obstet Gynecol; 2021 Nov; 60(6):983-994. PubMed ID: 34794761
[TBL] [Abstract] [Full Text] [Related]
20. Bioinformatic analysis of key pathways and genes shared between endometriosis and ovarian cancer.
Ni L; Chen Y; Yang J; Chen C
Arch Gynecol Obstet; 2022 May; 305(5):1329-1342. PubMed ID: 34727222
[TBL] [Abstract] [Full Text] [Related]
[Next]
